Copeland K R, Yatscoff R W
Department of Clinical Chemistry, Health Sciences Clinical Research Centre, Winnipeg, Manitoba, Canada.
Ther Drug Monit. 1991 Jul;13(4):281-8. doi: 10.1097/00007691-199107000-00001.
Seven cyclosporin G metabolites were isolated by high-performance liquid chromatography from the urine of normal subjects receiving the drug. The structure and purity of the metabolites were assessed by fast atom bombardment/mass spectroscopy, by proton nuclear magnetic resonance (NMR), and by 13C-NMR. The structural modifications of the cyclosporin G metabolites consisted primarily of hydroxylation and demethylation, as is the case for cyclosporin A metabolites. The immunosuppressive activities of the metabolites were tested in three separate in vitro systems: a primary and secondary mixed lymphocyte system, as well as a mitogen stimulated system. In general, the metabolites have immunosuppressive activity of less than 10% of cyclosporin G. The significance of these findings in relation to the therapeutic monitoring of cyclosporin G is discussed.
通过高效液相色谱法从接受环孢素G治疗的正常受试者尿液中分离出七种环孢素G代谢物。采用快原子轰击/质谱法、质子核磁共振(NMR)和13C-NMR对代谢物的结构和纯度进行了评估。环孢素G代谢物的结构修饰主要包括羟基化和去甲基化,环孢素A代谢物也是如此。在三个独立的体外系统中测试了这些代谢物的免疫抑制活性:一级和二级混合淋巴细胞系统以及丝裂原刺激系统。一般来说,这些代谢物的免疫抑制活性不到环孢素G的10%。讨论了这些发现与环孢素G治疗监测的相关性。